• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number VS-402
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Foreign Body Reaction (1868); Patient Problem/Medical Problem (2688)
Event Date 12/18/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Physician used venaseal closure system to treat 45cm of the great saphenous vein (gsv).The ifu was followed during preparation, procedure and post-procedure.It was reported treatment was completed without issue.Some months post procedure, patient developed two lesions at the surface of the skin.The cast of the glue was removed from one of the lesions.Patient is stable and lesions are reported as smaller and better.
 
Manufacturer Narrative
Additional information: patient is doing well and lesions are progressing.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Patient presented with symptoms approximately 3 months post procedure and was prescribed topical cream two days post onset of symptoms.The cast of glue was extruded through the first lesion.The second lesion will not require any treatment.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Image review: four photographic images were received of the patient symptoms from three office visits.Image one is from approximately 6 months post-procedure and shows three lesions of the patient¿s treated leg along with redness on the backside of the leg.The middle lesion shows a collection of purulent along the rim of the lesion.Image 2 is from approximately 9 months post-procedure and shows three lesions of the patient¿s treated leg.The lesions show healing progressing and smaller amount of purulent along the rim of the middle lesion.Images 3 and 4 are from 10 months post procedure.Image 3 show three lesions of the patient¿s treated leg.The lesions are darker than the surrounding skin.Image 4 is of an adhesive cast excised from the patient¿s leg from one of the lesions.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8873311
MDR Text Key153652268
Report Number9612164-2019-03277
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 10/31/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/08/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberVS-402
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/29/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age77 YR
-
-